AGM/EGMApr 28, 2026, 04:18 PM
CNTX to Hold 2026 Annual Meeting; Proposes 300M Authorized Shares
AI Summary
Context Therapeutics Inc. will hold its 2026 Annual Meeting of Stockholders virtually on Wednesday, June 24, 2026. Stockholders will vote on the election of seven director nominees, the ratification of CohnReznick LLP as the independent registered public accounting firm for fiscal year 2026, and a proposal to increase the number of authorized shares of common stock from 200,000,000 to 300,000,000. An additional proposal for adjournment is included if necessary to solicit further proxies for the share increase.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 24, 2026, at 8:00 a.m. ET.
- Proposes to elect seven director nominees to the Board of Directors.
- Seeks ratification of CohnReznick LLP as independent auditor for fiscal year 2026.
- Proposes to increase authorized common stock from 200,000,000 to 300,000,000 shares.
- Record date for voting is April 27, 2026, with 91,879,177 shares outstanding.
- Quorum requirement is 33 1/3% of outstanding shares, as per Nasdaq Listing Rule 5620(c).
Price Impact
More from CNTX